Comparative pharmacoepidemiological analysis on analgesics consumption in the Republic of Serbia and Nordic countries in the period 2015-2018

Author:

Krtinić DaneORCID,Milijašević BorisORCID,Dragić Aleksandra,Milijašević DraganaORCID,Lučić-Prokin AleksandraORCID,Nedin-Ranković GordanaORCID,Conić IrenaORCID,Todorović-Mitić Mirjana,Jovanović HristinaORCID,Trajković HristinaORCID,Pejčić Vuk

Abstract

Introduction/Aim. Analgesics are drugs used in the pain pharmacotherapy and are one of the most prescribed drugs in all countries. Modern pain pharmacotherapy involves the use of analgesic steps. The objective of this paper was to analyze the consumption of drugs used in the pain pharmacotherapy in the Republic of Serbia (RS), in the period from 2015 to 2018, and to compare the obtained results with the consumption of the mentioned drugs in the Kingdom of Norway (KN) and the Republic of Finland (RF) in the same time period interval. Material and methods. Data on drug consumption were taken from the website of the Agency for Medicines and Medical Devices of Serbia, the official website of the Norwegian Institute of Public Health and from the official website of the Finnish Medicines Agency. The consumption of medicines is monitored using the defined daily dose (DDD) methodology. Results. Paracetamol consumption was 13 to even 20 times lower in the RS compared to the KN and 10 to 15 times lower compared to the RF. The average consumption of diclofenac during the four observed years was about 30 DDD/1,000 inhabitants/day in the RS, about 7 in the KN and about 4 DDD/1,000 inhabitants/day in the RF. Conclusion. In the pain pharmacotherapy in the RS, the consumption of non-steroidal anti-inflammatory drugs is dominated by diclofenac, while in the KN and the RF ibuprofen and paracetamol from non-opioids.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Reference25 articles.

1. Aydede M. Does the IASP definition of pain need updating? Pain Rep 2019; 4(5): e777. https://doi.org/10.1097/PR9.0000000000000777;

2. Republička stručna komisija za izradu i implementaciju vodiča u kliničkoj praksi; Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje hroničnog bola maligne etiologije. Ministarstvo zdravlja Republike Srbije: Beograd, 2013. https://www.zdravlje.gov.rs/view_file.php?file_id =556&cache=sr;

3. Danilov A, Danilov A, Barulin A, et al. Interdisciplinary approach to chronic pain management. Postgrad Med 2020; 132(Suppl 3): 5-9. https://doi.org/10.1080/00325481.2020.1757305;

4. Stevanović P, Nešić D, Lađević N, et al. Medicina bola. CIBID, Medicinski fakultet, Univerzitet u Beogradu, Beograd, 2020;

5. Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm 2014; 71(1): 11-23. https://www.ptfarm.pl/pub/File/Acta_Poloniae/20 14/1/011.pdf;

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3